Hubei Hongyuan Pharmaceutical Technology Co., Ltd. Stock
Equities
301246
CNE100005ZB9
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.25 CNY | +2.81% | -7.41% | -45.15% |
Sales 2022 | 2.06B 285M | Sales 2023 | 2.05B 284M | Capitalization | 10.39B 1.43B |
---|---|---|---|---|---|
Net income 2022 | 435M 60.02M | Net income 2023 | 87M 12M | EV / Sales 2022 * | - |
Net cash position 2022 | 51.05M 7.04M | Net cash position 2023 | 1.83B 253M | EV / Sales 2023 | 4.17 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
116
x | Employees | 2,075 |
Yield 2022 * |
-
| Yield 2023 |
0.19% | Free-Float | 37.32% |
1 day | +2.81% | ||
1 week | -7.41% | ||
Current month | -7.41% | ||
1 month | -14.77% | ||
3 months | -32.50% | ||
6 months | -45.96% | ||
Current year | -45.15% |
Managers | Title | Age | Since |
---|---|---|---|
Shuang Xi Xu
CEO | Chief Executive Officer | 58 | - |
Gao Liang Lei
CHM | Chairman | 59 | - |
Ke Feng Zeng
DFI | Director of Finance/CFO | 39 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Qing Xie
BRD | Director/Board Member | 61 | - |
Si Yuan Cheng
BRD | Director/Board Member | 51 | - |
Zhi Hua Deng
BRD | Director/Board Member | 54 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 14.25 | +2.81% | 3,010,600 |
24-06-06 | 13.86 | -4.15% | 4,340,386 |
24-06-05 | 14.46 | -1.90% | 2,771,372 |
24-06-04 | 14.74 | -0.54% | 2,242,843 |
24-06-03 | 14.82 | -3.70% | 3,984,400 |
End-of-day quote Shenzhen S.E., June 06, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-45.15% | 786M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
+11.88% | 216B | |
-0.78% | 219B | |
+5.90% | 164B |
- Stock Market
- Equities
- 301246 Stock